Lloyds Group Acquires Significant Stake in Bharat Wire Ropes

HCP Investments Sells Minority Shareholding in Ind-Swift Laboratories
Back to News
Market1h agoPositiveMedium ImpactShort Term

Lloyds Group Acquires Significant Stake in Bharat Wire Ropes HCP Investments Sells Minority Shareholding in Ind-Swift Laboratories

Detailed Analysis

Lloyds Group Acquires Significant Stake in Bharat Wire Ropes

On April 17, Lloyds Group companies acquired a more than 5 percent equity stake in Bharat Wire Ropes, a wire rope manufacturer, through open market transactions. The transaction was reflected in the trading volumes on Friday, with Bharat Wire Ropes shares reaching a 20 percent upper circuit, the highest level since July 10, 2025, at Rs 221.96.

The acquisition was made by Lloyds Metals and Energy, which bought 20 lakh shares in Bharat Wire Ropes at Rs 193.42 per share, and Lloyds Enterprises, which acquired 11.46 lakh shares at Rs 215.17 per share and 5 lakh shares at Rs 215 per share. This represented a 5.31 percent equity stake worth Rs 74.11 crore.

In contrast, Resonance Opportunities Fund sold 17.02 lakh shares (2.48 percent stake) in the wire rope maker at Rs 193 per share, valued at Rs 32.84 crore.

Bulk Deal Comparison

| Company | Shares Bought/Sold | Stake | Price per Share | Value | | --- | --- | --- | --- | --- | | Bharat Wire Ropes | Lloyds Metals and Energy | 20 lakh | Rs 193.42 | Rs 38.68 crore | | Bharat Wire Ropes | Lloyds Enterprises | 16.46 lakh | Rs 215.17 | Rs 35.14 crore | | Bharat Wire Ropes | Resonance Opportunities Fund | 17.02 lakh | Rs 193 | Rs 32.84 crore | | Ind-Swift Laboratories | HCP Investments | 48 lakh | Rs 134.18 | Rs 64.4 crore | | Ind-Swift Laboratories | HCP Investments | (previous session) | | | Rs 21.03 crore | | Ind-Swift Laboratories | Sahastraa Advisors | 4.75 lakh | Rs 131.74 | Rs 6.25 crore | | Ind-Swift Laboratories | Nova Global Opportunities Fund PCC - Touchstone | 8.03 lakh | Rs 138.07 | Rs 11.13 crore | | Anzen India Energy Yield Plus Trust | Prazim Trading and Investment Company | 32 lakh | Rs 125 | Rs 40 crore | | Anzen India Energy Yield Plus Trust | Famy Steri | 45 lakh | Rs 125 | Rs 56.25 crore |

On the National Stock Exchange, Ind-Swift Laboratories shares tanked 9.32 percent to Rs 131.86, following HCP Investments' sale of 48 lakh shares (5.53 percent equity stake) at Rs 134.18 per share, valued at Rs 64.4 crore. This sale is in addition to 1.12 percent shares sold in the previous session. With Friday's bulk deal, HCP Investments offloaded a total 6.65 percent stake in two days against its 8.65 percent shareholding as of February 24, 2026.

However, Sahastraa Advisors bought 4.75 lakh Ind-Swift Labs shares at Rs 131.74 per share, and Nova Global Opportunities Fund PCC - Touchstone picked up 8.03 lakh shares at Rs 138.07 per share.

Meanwhile, Prazim Trading and Investment Company has bought 32 lakh units in Anzen India Energy Yield Plus Trust at Rs 125 per unit, valued at Rs 40 crore. However, Famy Steri sold 45 lakh units for Rs 56.25 crore at the same price.

Investor Takeaway

Investors should be cautious of the short-term market impact of this acquisition on Bharat Wire Ropes' stock price.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.